Orexo AB (publ) (STO:ORX)
21.00
+1.18 (5.95%)
May 26, 2026, 5:29 PM CET
Orexo AB Revenue
Orexo AB had revenue of 5.00M SEK in the quarter ending March 31, 2026, a decrease of -62.12%. This brings the company's revenue in the last twelve months to 17.80M. In the year 2025, Orexo AB had annual revenue of 26.00M, down -12.46%.
Revenue (ttm)
17.80M
Revenue Growth
-12.46%
P/S Ratio
41.20
Revenue / Employee
273.85K
Employees
65
Market Cap
733.35M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 26.00M | -3.70M | -12.46% |
| Dec 31, 2024 | 29.70M | -609.10M | -95.35% |
| Dec 31, 2023 | 638.80M | 14.50M | 2.32% |
| Dec 31, 2022 | 624.30M | 59.30M | 10.50% |
| Dec 31, 2021 | 565.00M | -98.60M | -14.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BioGaia AB | 1.54B |
| EQL Pharma AB | 432.66M |
| Cinclus Pharma Holding AB | 67.51M |
| Nanexa AB | 54.32M |
| Enzymatica AB | 53.06M |
| Cereno Scientific AB | 44.27M |
| Newbury Pharmaceuticals AB | 32.78M |
| Moberg Pharma AB | 14.59M |
Orexo AB News
- 4 days ago - Orexo AB Slides: ABGSC Investor Days - Filings
- 4 weeks ago - Orexo AB Earnings Call Transcript: Q1 2026 - Transcripts
- 4 weeks ago - Orexo AB Quarterly report: Q1 2026 - Filings
- 4 weeks ago - Orexo AB Slides: Q1 2026 - Filings
- 2 months ago - Orexo AB Transcript: R&D Day - Transcripts
- 2 months ago - Orexo AB Slides: R&D Day - Filings
- 2 months ago - Orexo AB Slides: FY 2026 - Filings
- 2 months ago - Invitation & Agenda: Orexo R&D Day on March 24 - PRNewsWire